Thanks to funding from the British Heart Foundation (BHF), researchers from the University of Oxford discovered a new method to detect chemotherapy-caused heart damage. The high-tech scanning technique can see if chemo treatment is damaging the patient's heart before any actual symptoms surface.
Chemotherapy drugs such as Doxorubicin can lead to heart failure, a devastating reality thousands of cancer survivors have had to face. Heart failure symptoms such as breathlessness typically only appear after the heart has undergone irreversible damage. There are currently no non-invasive ways to see if heart damage is occurring. However, this new research suggests that hyperpolarized MRI imaging could identify damage early on by scanning deeper into heart cells and preventative action can be taken.